Relationship between outflow obstruction and left ventricular functional impairment in hypertrophic cardiomyopathy: a

Aloir Q Araujo1, Edmundo Arteaga, Barbara M Ianni

  • 1Cardiomyopathies Division-Heart Institute (InCor), University of São Paulo Medical School, Av. Eneas Carvalho Aguiar 44, 05403-900 São Paulo, SP, Brazil. aloirqueiroz@cardiol.br

Insights

Left ventricular outflow tract (LVOT) obstruction in hypertrophic cardiomyopathy (HCM) is linked to more severe hypertrophy and impaired left ventricular (LV) function. This obstruction independently worsens LV systolic and diastolic abnormalities, impacting patient outcomes.

Area of Science:

  • Cardiology
  • Echocardiography
  • Cardiovascular Physiology

Background:

  • Left ventricular outflow tract (LVOT) obstruction is a significant complication in hypertrophic cardiomyopathy (HCM).
  • LVOT obstruction is associated with adverse clinical outcomes in HCM patients.

Purpose of the Study:

  • To investigate the relationship between LVOT obstruction and left ventricular (LV) structure and function in HCM patients.
  • To determine if LVOT obstruction is an independent predictor of LV functional abnormalities beyond hypertrophy.

Main Methods:

  • A detailed Doppler echocardiographic study was conducted on 178 selected HCM patients.
  • Patients were categorized into obstructive (resting peak gradient ≥ 30 mmHg) and non-obstructive groups.
  • Correlations between LVOT peak gradient, hypertrophy, and LV systolic/diastolic function parameters were analyzed.

Main Results:

  • Obstructive HCM patients exhibited greater hypertrophy and poorer LV systolic and diastolic function compared to non-obstructive patients.
  • LVOT peak gradient positively correlated with hypertrophy and negatively with mitral annulus systolic and early diastolic velocities.
  • Multiple regression analysis identified E/Ea ratio, LV maximal thickness, and left atrial size as determinants of LVOT gradient.

Conclusions:

  • LVOT obstruction in HCM is associated with increased LV hypertrophy and significantly impaired LV systolic and diastolic function.
  • LVOT obstruction is an independent determinant of LV functional abnormalities in HCM, irrespective of hypertrophy severity.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...